Evaluate and develop product development strategies for pharmaceutical products (drugs, biologics, advanced therapies) focusing on clinical-commercial convergence that encompasses all phases of development from discovery to market, including preclinical
Responsible for shaping and executing the R&D strategy within the oncology therapeutic area as well as leading strategic partnerships in the field. This role drives innovation, identifies high-impact opportunities, and steers cross-functional efforts to
Responsible for shaping and delivering the UK medical strategy, driving education, evidence generation, and engagement with healthcare professionals and key opinion leaders in the diabetes space. The role leads cross-functional collaboration
Act as a scientific and clinical expert in diabetes and CGM, ensuring the organisation remains at the forefront of emerging evidence and practice. Provide authoritative, evidence-based guidance on clinical data, device utilisation, and patient management
Develop and lead clinical biomarker strategies across Ipsen's oncology and rare disease portfolio to support critical development and portfolio decisions. Define biomarker plans to support target engagement, pharmacodynamic and mechanistic understanding,
This role is responsible for the day‑to‑day management and execution of key quality assurance activities related to the manufacture of commercial and investigational medicinal products. Core responsibilities include oversight of quality systems,
A key focus area of the position is the preparation of regulatory CMC documentation for small molecule products during development and commercial stage, in a manner that is scientifically sound, commercially viable and in accordance with current
You will be responsible for managing the required quality activities and documentation associated with the portfolio of CMOs, ensuring that the CMOs manufacture and deliver products in compliance with Sanofi’s requirements specifications and regulations
Lead oncology small molecule discovery programs from target identification and validation through PCC nomination. Integrate expertise across biology, medicinal chemistry, in vitro and in vivo pharmacology, DMPK, translational sciences, biomarkers,
Own the end-to-end lifecycle of Pharmacovigilance Agreements (PVAs), including development, execution, maintenance, and termination where applicable, along with all associated deliverables. Contribute to strategy setting in collaboration with line
You will serve as a key technical leader driving route scouting, synthetic design, process development, and process characterization for our development programs. You will apply a strong foundation in modern synthetic organic chemistry and process
This role will involve designing and overseeing experimental studies, analysing results, and generating high-quality data packages and presentations to support internal decision making and customer engagement. The successful candidate will work closely
You will be responsible for shaping and executing the European Medical Affairs strategy across development, launch readiness, commercialization, and lifecycle management of our endocrinology portfolio. This role combines scientific leadership, functional
Ensure that all NPI and Commercial Products manufactured at AbbVie Biologics are in accordance with the relevant GMPs. Ownership and Accountability for the Management and oversight for effective product transfer of NPIs and transfer to commercial
You'll be the primary regulatory CMC voice on cross-functional matrix teams, covering everything from early clinical trial applications through to new marketing authorizations, post-approval changes, and full lifecycle management. That means you won't
Lead and ensure compliance of global CQA processes across multiple sites; Act as key Quality partner for cross-functional stakeholders (e.g. Clinical Trial Teams, Biometry, CROs); Drive continuous improvement initiatives and proactively identify risks and
You will lead a key expansion area within our neuroimmunology strategy, focusing on how peripheral immune mechanisms influence neurological disease of the peripheral and central nervous systems. You will shape scientific direction, build and lead a
You will lead TxM strategy and activities in the project Core Team and represent non-clinical DMPK strategy from late research onward—partnering across ADME/DMPK, non-clinical safety, quantitative pharmacology, formulation, and clinical pharmacology to
The Senior GVP QA Manager is responsible for supporting the maintenance and continuous improvement of the global Pharmacovigilance (PV) System to ensure that Santhera fulfils its legal PV obligations as both a Marketing Authorisation Holder (MAH) and
The role is responsible for formulation design and process development across various modalities, with a focus on ADCs, within the Formulation Technology Research Laboratories (FTRL). Responsibilities include supporting the preparation of regulatory
In this assignment the GPH will be accountable for the compound clinical development strategy and execution, with a focus on studies for regulatory purposes and including budget planning. The GPH will collaborate with the Principal Clinical Lead (PCL) and